Brown-Forman Corporation
BF-B
$26.64
+4.43%
Brown-Forman Corporation is a leading global producer and marketer of premium alcoholic beverages, operating in the Beverages - Wineries & Distilleries industry. The company is distinguished by its iconic portfolio, most notably the Jack Daniel's brand, which positions it as a dominant player in the American whiskey and global spirits market. The current investor narrative revolves around navigating a challenging consumer environment, with recent financial results showing modest revenue growth but significant stock price underperformance relative to the broader market, raising questions about near-term demand trends and the company's ability to sustain its premium valuation.…
BF-B
Brown-Forman Corporation
$26.64
Investment Opinion: Should I buy BF-B Today?
Rating & Thesis: Hold. BF-B is a high-quality, defensive business caught in a growth slowdown, making it fairly valued at current levels with limited near-term catalysts for outperformance. The neutral analyst consensus and mixed recent rating actions support this view, as the average revenue estimate of $4.38B implies only modest growth.
Supporting Evidence: The hold rating is supported by four key data points: 1) A forward P/E of 15.45x is reasonable but not deeply cheap for a company with ~3% revenue growth. 2) Robust profitability with a 60.87% gross margin and strong FCF generation of $730M TTM. 3) A solid 3.55% dividend yield supported by a 59.7% payout ratio. 4) The stock trades 11% above its 52-week low, suggesting most near-term bad news is priced in, but 18% below its high indicates limited upside momentum.
Risks & Conditions: The two biggest risks are a further deceleration in revenue growth below 2% and a breakdown below the $22.61 support level. This Hold would upgrade to a Buy if the forward P/E compresses below 14x (offering a greater margin of safety) or if quarterly revenue growth re-accelerates above 5% YoY. It would downgrade to a Sell if revenue turns negative or if the stock breaks below $22.61 on high volume. Relative to its own history and strong fundamentals, the stock appears fairly valued, not deeply undervalued.
Sign up to view all
BF-B 12-Month Price Forecast
The analysis adopts a neutral stance based on a clash between deteriorating momentum and attractive defensive fundamentals. The stock's low beta and high profitability provide a floor, but the lack of revenue acceleration and clear technical downtrend cap the upside. Confidence is medium due to the high uncertainty reflected in mixed analyst actions. The stance would upgrade to bullish on a confirmed break above the $30.39 resistance level with improving volume, signaling a trend reversal. It would turn bearish on a close below the $22.61 support, which would invalidate the valuation support thesis.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brown-Forman Corporation's 12-month outlook, with a consensus price target around $34.63 and implied upside of +30.0% versus the current price.
Average Target
$34.63
13 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
13
covering this stock
Price Range
$21 - $35
Analyst target range
Analyst coverage is limited, with only 6 analysts providing estimates, indicating this is not a widely followed large-cap name. The consensus sentiment appears neutral to cautious, as evidenced by recent institutional rating actions where firms like Citigroup and JP Morgan upgraded from Sell/Underweight to Neutral, but Bernstein downgraded from Outperform to Market Perform. The average revenue estimate for the period is $4.38 billion, with a low of $4.25 billion and a high of $4.49 billion, showing a relatively tight range of expectations. The wide target price range and mixed recent rating actions signal high uncertainty and a lack of strong conviction among analysts, which is typical for a stock undergoing a fundamental re-rating and facing near-term headwinds in its core markets.
Bulls vs Bears: BF-B Investment Factors
The evidence currently tilts bearish, primarily due to the stock's persistent price decline, slowing revenue growth, and lack of positive catalysts outweighing its strong fundamentals. The bull case rests on valuation support and defensive financials, while the bear case emphasizes growth stagnation and technical breakdown. The single most important tension in the investment debate is whether the company's iconic brand portfolio and fortress balance sheet can overcome decelerating top-line growth to justify a premium multiple, or if the current slowdown is a structural rather than cyclical issue, leading to a prolonged period of valuation compression.
Bullish
- Strong Profitability and Cash Flow: The company maintains robust gross margins of 60.87% and generates substantial free cash flow, with TTM FCF of $730 million. This financial strength provides a defensive cushion, funding a 3.55% dividend yield and share buybacks without reliance on debt, as evidenced by a healthy debt-to-equity ratio of 0.535.
- Attractive Valuation Near Historical Lows: The stock trades at a trailing P/E of 16.81x and a forward P/E of 15.45x, which is near the lower end of its multi-year historical range (from 12.09x to 79.75x). This suggests the market has priced in significant pessimism, potentially offering a margin of safety if fundamentals stabilize.
- Solid Financial Health and Low Volatility: A strong current ratio of 3.24 and a low beta of 0.354 indicate a resilient balance sheet and lower volatility than the market. This defensive profile is attractive in uncertain economic environments, limiting downside risk relative to the broader equity market.
- Diversification into Growth Segments: While Jack Daniel's dominates (75% of revenue), the Ready-to-Drink (RTD) segment contributed $146 million last quarter. This represents a strategic pivot into a higher-growth category, offering a potential avenue to re-accelerate top-line growth beyond the core whiskey business.
Bearish
- Persistent Revenue Growth Slowdown: Quarterly revenue growth has decelerated to just 2.71% YoY, a stark contrast to the company's premium valuation multiples. This tepid growth, amidst a challenging consumer environment, raises questions about the sustainability of its market position and pricing power.
- Severe Technical and Relative Underperformance: The stock is down 13.15% over six months and has shown a -25.16% relative strength versus the S&P 500 over the past year. Trading 18% below its 52-week high and in a sustained downtrend, this reflects persistent selling pressure and a lack of positive catalysts.
- High Dependence on a Single Brand: Approximately 75% of revenue comes from the Whiskey segment, overwhelmingly driven by Jack Daniel's. This concentration creates significant vulnerability to any brand-specific missteps, competitive pressures, or shifts in consumer preference away from American whiskey.
- Lack of Analyst Conviction and Catalysts: With only 6 analysts covering the stock and recent mixed rating actions (both upgrades and downgrades to Neutral), there is a clear lack of strong bullish conviction. The wide range of analyst estimates underscores high uncertainty and a scarcity of near-term positive catalysts.
BF-B Technical Analysis
The stock is in a sustained downtrend, evidenced by a 1-year price change of -0.79% and a more severe 6-month decline of -13.15%. Currently trading at $26.16, the price sits approximately 11% above its 52-week low of $22.61 and 18% below its 52-week high of $31.92, placing it in the lower quartile of its annual range, which suggests a potential value opportunity but also reflects persistent selling pressure. Recent momentum shows a slight recovery with a 3-month gain of 4.52%, but this is overshadowed by a 1-month decline of -3.04%, indicating the short-term bounce is losing steam and the longer-term downtrend remains dominant. Key technical support is clearly defined at the 52-week low of $22.61, while resistance lies near the recent highs around $30.39; a sustained break below support would signal a continuation of the bearish trend, while a move above resistance could indicate a more meaningful recovery. The stock's beta of 0.354 indicates it is significantly less volatile than the broader market, which, while reducing downside risk during market stress, also suggests it has lacked the momentum to participate in broader rallies, as seen in its -25.16% relative strength versus the S&P 500 over the past year.
Beta
0.35
0.35x market volatility
Max Drawdown
-51.9%
Largest decline past year
52-Week Range
$23-$32
Price range past year
Annual Return
+7.4%
Cumulative gain past year
| Period | BF-B Return | S&P 500 |
|---|---|---|
| 1m | +3.7% | +0.7% |
| 3m | +17.9% | +15.1% |
| 6m | -4.8% | +9.7% |
| 1y | +7.4% | +25.0% |
| ytd | +3.8% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BF-B Fundamental Analysis
Revenue growth has been modest but positive, with the latest quarterly revenue at $1.063 billion, representing a year-over-year growth of 2.71%. Segment data reveals the core Whiskey business, led by Jack Daniel's, generated $797 million, or approximately 75% of total revenue, while the high-growth Ready-to-Drink (RTD) segment contributed $146 million, indicating diversification efforts are gaining traction but remain secondary to the flagship brand. The company is highly profitable, with net income of $267 million and a robust gross margin of 60.87% for the quarter, though operating income of $343 million yields an operating margin of 32.27%, showing strong pricing power and brand equity typical for a premium spirits company. Financial health is solid, with a strong balance sheet evidenced by a current ratio of 3.24, a manageable debt-to-equity ratio of 0.535, and substantial free cash flow generation, with TTM free cash flow of $730 million providing ample liquidity for dividends, share buybacks, and organic investment without reliance on external financing.
Quarterly Revenue
$1.1B
2026-01
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.60%
Latest Quarter
Free Cash Flow
$730000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BF-B Overvalued?
Given a positive net income of $267 million, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 16.81x, while the forward PE is lower at 15.45x, indicating the market expects modest earnings growth in the coming year. Compared to the provided valuation data, the stock's trailing PE of 16.81x and forward PE of 15.45x must be assessed against sector averages; however, specific industry average multiples are not provided in the data, limiting a direct peer comparison. Historically, the stock's own PE ratio has fluctuated significantly, as seen in the historical ratios data where it ranged from a low of 12.09x in Q3 2026 to a high of 79.75x in Q3 2023; the current trailing PE of 16.81x sits near the lower end of this multi-year range, suggesting the market's expectations have been reset to more conservative levels, potentially offering a valuation floor if fundamentals stabilize.
PE
16.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~80x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
12.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is revenue concentration, with 75% of sales tied to the Whiskey segment, making the company highly sensitive to the performance of Jack Daniel's. While profitability is strong (32.27% operating margin), the modest 2.71% YoY revenue growth suggests potential margin pressure if the company cannot pass on cost increases or volume declines accelerate. The dependence on continued growth to justify its current P/E of 16.81x is a key risk, as any earnings miss could trigger further multiple contraction given the stock's historical P/E volatility.
Market & Competitive Risks: The stock trades at a premium valuation with a P/S ratio of 3.06x and an EV/EBITDA of 12.5x, which is vulnerable to compression if growth remains anemic, especially in a higher interest rate environment that pressures consumer discretionary spending. Competitive disruption from newer spirit categories and private label brands poses a threat to market share. The stock's low beta of 0.354, while defensive, also indicates it has failed to participate in market rallies, highlighting sector rotation risk away from stagnant consumer staples.
Worst-Case Scenario: The worst-case scenario involves a continued deterioration in consumer demand for premium spirits, leading to a sequential decline in Jack Daniel's volumes. This could be compounded by a recessionary environment, triggering analyst downgrades and a re-rating towards the stock's historical P/E low of 12.09x. Such a scenario could see the stock retest and break its 52-week low of $22.61, implying a downside of approximately -13.5% from the current price of $26.16. A more severe drawdown, aligning with the stock's maximum historical drawdown of -51.89%, is less likely given the current solid balance sheet but remains a tail risk.
FAQ
The key risks are, in order of severity: 1) Revenue Concentration Risk: 75% of sales depend on the Whiskey segment, primarily Jack Daniel's, making the company vulnerable to brand-specific issues. 2) Growth Stagnation Risk: Quarterly revenue growth of only 2.71% may not support the current valuation if it decelerates further. 3) Valuation Compression Risk: Trading at a forward P/E of 15.45x, any earnings disappointment could trigger a re-rating towards historical lows. 4) Technical Breakdown Risk: A sustained break below the $22.61 support level could lead to a swift decline of 13% or more, as seen in the recent downtrend.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock range-bound between $26 and $28, as low-single-digit growth persists. The Bull Case (25% probability) targets $30.39 to $31.92, driven by growth re-acceleration and multiple expansion. The Bear Case (15% probability) warns of a drop to $22.61-$24.00 if consumer demand weakens further. The most likely scenario is the Base Case, predicated on the assumption that the company's strong brand equity and cash flows prevent a collapse, but growth headwinds prevent a significant rally. The weighted average suggests a modest upside from current levels is possible but not guaranteed.
BF-B appears fairly valued. Its forward P/E of 15.45x is reasonable but not cheap for a company with modest growth, sitting near the lower end of its own volatile historical P/E range (12.09x to 79.75x). Compared to sector averages, its P/S of 3.06x and EV/EBITDA of 12.5x likely command a premium due to its strong brand and margins, but this premium is justified only if growth stabilizes. The market is currently pricing in a scenario of low-single-digit growth with high profitability, which aligns with recent fundamentals. It is not deeply undervalued, nor is it egregiously overvalued.
BF-B is a good buy only for specific investor profiles. For a conservative, income-focused investor seeking low volatility (beta 0.354) and a solid 3.55% dividend, the current price near the lower end of its range offers a reasonable entry point. However, for growth investors, it is not a good buy given its anemic 2.71% revenue growth and lack of near-term catalysts. The risk/reward is balanced, with an implied upside to resistance near $30 (approx. +15%) and a downside risk to the 52-week low of $22.61 (approx. -13.5%). It is a 'Hold' for most, and a cautious 'Buy' only for those prioritizing defense and income.
BF-B is more suitable for a long-term investment horizon of 3-5 years. Its low beta and dividend profile are not conducive to short-term trading, as the stock lacks momentum and clear catalysts for a quick rebound. For the long-term investor, the thesis is that the company's iconic brands and financial strength will eventually allow it to navigate current headwinds and return to a healthier growth trajectory, rewarding patient capital with dividend income and potential capital appreciation. A short-term trader would find better opportunities elsewhere, given the stock's -13.15% six-month decline and weak relative strength.